Summary
Diabetic nephropathy is one of the major long term complications responsible for mortality in diabetes mellitus. While strict metabolic control of diabetes probably has a positive influence on kidney disease, most evidence supports the view that the process leading to end-stage renal failure has become independent of the metabolic disturbances of diabetes, and that haemodynamic factors in established nephropathy have become the predominant causes of progression of renal damage. In particular, increased intraglomerular pressure is thought to play a crucial part in the development of diabetic nephropathy. Therefore, drugs that can reduce intraglomerular pressure are of interest in treatment of hypertension in diabetic patients. The angiotensin-converting enzyme (ACE) inhibitors have been shown to reduce intraglomerular pressure in animal studies, and the use of these drugs to treat insulin-dependent diabetics with hypertension has produced a reduction in the rate of decline of glomerular filtration rate. Although some β-blockers can also have beneficial effects on renal function, they may produce unwanted metabolic effects. Thus the ACE inhibitors seem to be the most suitable antihypertensive drugs for diabetic patients.
Similar content being viewed by others
References
Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type I (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496–501, 1983
Anderson S, Brenner BM. The role of intraglomerular pressure in the initiation and progression of renal disease. Journal of Hypertension 4 (Suppl. 5): S236–S238, 1986
Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. Journal of Clinical Investigation 76: 612–619, 1985
Bauer JH. Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. American Journal of Medicine 77 (Suppl. 2A): 43–51, 1984
Bauer JH, Gaddy P. Effects of enalapril alone, and in combination with hydrochlorothiazide, on renin-angiotensin-aldosterone, renal function, salt and water excretion, and body fluid composition. American Journal of Kidney Diseases 6: 222–232, 1985
Bauer JH, Reams G. Renal effects of angiotensin converting enzyme inhibitors in hypertension. American Journal of Medicine 81 (Suppl. 4C): 19–27, 1986
Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, et al. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. British Medical Journal 293: 471–474, 1986
Brenner BM. Nephron adaptation renal injury or ablation. American Journal of Physiology 249: 324–337, 1985
Connell JMC. Treating the diabetic hypertensive. ACE Report SBJ 87-R-911-G(34): 1–6, 1987
Drury PL. Diabetes and arterial hypertension. Diabetologia 24: 2–9, 1983
Drury PL, Smith GM, Ferriss JB. Increased vasopressor responsiveness to angiotensin II in type I (insulin-dependent) diabetic patients without complications. Diabetologia 27: 174–179, 1984
Hommel E, Parving H-H, Mathieson E, Edsberg B, Damkjaer M, et al. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. British Medical Journal 293: 467–470, 1986
Jackson B, Debrevi L, Whitty M, Johnston CI. Progression of renal disease: effects of different classes of antihypertensive therapy. Journal of Hypertension 4 (Suppl. 5): S269–S271, 1986
Kaplan NM, Rosenstock J, Raskin P. A differing view of treatment of hypertension in patients with diabetes mellitus. Archives of Internal Medicine 147: 1160–1162, 1987
Knowler WC. Magnitude of the renal failure problem in diabetes. Kidney International 6: 2–7, 1974
Mogensen CE, Steffes MW, Dechert T, Christiansen JS. Functional and morphological renal manifestations in diabetes mellitus. Diabetologia 21: 89–93, 1981
Parving H-H, Christiansen JS, Noer I, Frouier B, Mogensen CE. The effect of glucagon infusion on kidney function in shortterm insulin-dependent juvenile diabetes. Diabetologia 19: 350–354, 1980
Parving H-H, Anderson AR, Hommel E, Smidt U. Effects of longterm antihypertensive treatment on kidney function in diabetic nephropathy. Hypertension 7 (Suppl. II): 114–117, 1985a
Parving H-H, Andersen AR, Hommel E, Smidt U. Effect of longterm antihypertensive treatment of kidney function in diabetic nephropathy. Hypertension 7 (Suppl. II): 114–117, 1985b
Simon G, Morioka S, Snyder DK, Cohn JN. Increased renal plasma flow in long-term enalapril treatment of hypertension. Clinical Pharmacology and Therapeutics 34: 459–65, 1983
Wiseman MJ, Saunders AJ, Keen H, Viberti G. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. New England Journal of Medicine 312: 617–21, 1985
The Working Group on Hypertension in Diabetes. Statement of hypertension in diabetes mellitus. Archives of Internal Medicine 147: 830–842, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scherstén, B. Effects of Antihypertensive Therapy on Kidney Function in Diabetic Patients. Drugs 35 (Suppl 5), 59–61 (1988). https://doi.org/10.2165/00003495-198800355-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198800355-00010